We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
AUM
$9.16B
AUM Growth
-$13.2B
Cap. Flow
-$10.8B
Cap. Flow %
-117.92%
Top 10 Hldgs %
34.38%
Holding
2,371
New
451
Increased
532
Reduced
695
Closed
657

Sector Composition

Rank Sector Weight
1 Technology 8.09%
2 Financials 7.11%
3 Healthcare 5.24%
4 Communication Services 5.21%
5 Consumer Discretionary 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNRG icon
1351
PrimeEnergy Resources
PNRG
$324M
$298K ﹤0.01%
+1,742
New +$280K
BKTI icon
1352
BK Technologies
BKTI
$289M
$298K ﹤0.01%
+3,990
New +$286K
MSGE icon
1353
Madison Square Garden
MSGE
$3.76B
$297K ﹤0.01%
+5,518
New +$265K
REFI
1354
Chicago Atlantic Real Estate Finance
REFI
$258M
$297K ﹤0.01%
+24,253
New +$310K
EPR icon
1355
EPR Properties
EPR
$4.6B
$295K ﹤0.01%
5,919
-9,978
-63% -$519K
KRNY icon
1356
Kearny Financial
KRNY
$602M
$295K ﹤0.01%
+39,795
New +$275K
ASO icon
1357
Academy Sports + Outdoors
ASO
$3.1B
$294K ﹤0.01%
+5,894
New +$292K
DKS icon
1358
Dick's Sporting Goods
DKS
$18.4B
$293K ﹤0.01%
1,481
-1,296
-47% -$283K
BBNX
1359
Beta Bionics
BBNX
$781M
$293K ﹤0.01%
+9,607
New +$257K
CACI icon
1360
CACI
CACI
$14.8B
$292K ﹤0.01%
+548
New +$310K
RSI icon
1361
Rush Street Interactive
RSI
$2.92B
$292K ﹤0.01%
+15,007
New +$277K
AAT
1362
American Assets Trust
AAT
$1.37B
$291K ﹤0.01%
+15,371
New +$297K
THO icon
1363
Thor Industries
THO
$4.24B
$291K ﹤0.01%
+2,832
New +$294K
NEU icon
1364
NewMarket
NEU
$8.46B
$290K ﹤0.01%
422
-795
-65% -$607K
COKE icon
1365
Coca-Cola Consolidated
COKE
$12B
$290K ﹤0.01%
+1,890
New +$277K
EXP icon
1366
Eagle Materials
EXP
$6.52B
$289K ﹤0.01%
1,399
-189
-12% -$41.7K
ELAN icon
1367
Elanco Animal Health
ELAN
$11.4B
$288K ﹤0.01%
12,744
-6,938
-35% -$151K
PLMR icon
1368
Palomar
PLMR
$3.51B
$288K ﹤0.01%
2,138
-8,341
-80% -$1.02M
SNDR icon
1369
Schneider National
SNDR
$6.16B
$288K ﹤0.01%
10,860
-28,739
-73% -$678K
OWL icon
1370
Blue Owl Capital
OWL
$19.2B
$287K ﹤0.01%
+19,237
New +$301K
SANA icon
1371
Sana Biotechnology
SANA
$1.03B
$287K ﹤0.01%
+70,607
New +$316K
IE icon
1372
Ivanhoe Electric
IE
$1.78B
$287K ﹤0.01%
17,974
-32,614
-64% -$467K
RDVT icon
1373
Red Violet
RDVT
$1.12B
$286K ﹤0.01%
+5,030
New +$273K
ELDN icon
1374
Eledon Pharmaceuticals
ELDN
$285M
$286K ﹤0.01%
+195,757
New +$465K
ORKA
1375
Oruka Therapeutics
ORKA
$6.23B
$285K ﹤0.01%
+9,416
New +$262K

Similar funds

Brevan Howard Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Brevan Howard Capital Management held 2,371 positions worth $9.16B, down 59% from $22.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Brevan Howard Capital Management withdrew a net $10.8B in Q4 2025, closing 657 positions and reducing 695 holdings. Its most notable exit was Insmed, an estimated $42.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 4.4% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Brevan Howard Capital Management opened a new position in First Trust Small Cap BuyWrite Income ETF worth $452M.

  • Brevan Howard Capital Management's largest Q4 2025 buy was First Trust Small Cap BuyWrite Income ETF: 57,081,120 shares worth $452M.
  • Brevan Howard Capital Management added most to Walmart Inc in Q4 2025, an estimated $84M increase.
  • Brevan Howard Capital Management's biggest Q4 2025 reduction was iShares Bitcoin Trust, cutting an estimated $1.77B.
  • Brevan Howard Capital Management fully exited Insmed in Q4 2025, selling an estimated $42.3M.
  • Brevan Howard Capital Management's ten largest holdings make up 34% of its $9.16B portfolio in Q4 2025.
  • Brevan Howard Capital Management opened 451 new positions and closed 657 in Q4 2025.
  • Brevan Howard Capital Management's portfolio value fell 59% quarter-over-quarter to $9.16B.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.